Study: Metformin combined with insulin does not reduce pregnancy outcome risks compared to placebo

A recent UNC-Chapel Hill School of Medicine study has concluded that metformin—a drug used to control high blood sugar—along with insulin did not reduce risks for adverse neonatal outcomes compared with a placebo along with insulin in pregnancies with type 2 diabetes.

Leave A Comment

Your email address will not be published. Required fields are marked *